Mubadala Launches Mubadala Bio to Strengthen UAE's Life Sciences Sector and National Drug Security
Mubadala Investment Company PJSC (Mubadala), the Abu Dhabi-based sovereign investor, has officially launched “Mubadala Bio,” a new national life sciences company aimed at transforming healthcare outcomes in the UAE and globally. The initiative marks a major strategic milestone in advancing national healthcare resilience, enhancing local pharmaceutical manufacturing, and supporting the UAE’s long-term economic diversification goals.
Mubadala Bio is set to play a critical role in reinforcing national drug security while positioning Abu Dhabi as a regional hub for life sciences. The company's extensive manufacturing and distribution network spans 10 facilities across Asia, Africa, and Europe, with six located within the UAE. These sites serve over 100 countries and offer a combined manufacturing capacity exceeding 2.5 billion tablets and capsules and 120 million intravenous and injectable products annually, covering a total area of 110,000 square meters.
With a focus on integrated disease management, Mubadala Bio's portfolio addresses global health priorities through a continuum of care that includes prevention, diagnostics, treatment, supportive therapy, and complementary medicine. The company is also dedicated to forging partnerships with international industry leaders and renowned academic institutions to accelerate innovation in biopharmaceuticals and build world-class talent within the UAE.
Dr. Bakheet Al Katheeri, CEO of Mubadala's UAE Investments Platform, stated: “By launching Mubadala Bio, we are taking a transformative step towards strengthening national drug security and fostering innovation in life sciences. This positions Mubadala at the forefront of the industry, enabling us to drive long-term economic growth, build a resilient life sciences ecosystem, and elevate Abu Dhabi’s role in delivering impactful health solutions on a global scale.”
Ismail Ali Abdulla, Executive Director of UAE Clusters at Mubadala's UAE Investments Platform, added: “With the launch of Mubadala Bio, we are proud to take a significant step forward in supporting the UAE’s ambition to be a global leader in the life sciences industry. By focusing on local manufacturing and enhancing our distribution and logistics capabilities, we are building a more resilient and self-sustaining life sciences sector, one that responds to today’s needs while preparing for tomorrow’s challenges.”
Mubadala Bio will showcase its capabilities for the first time at Make it in the Emirates 2025, underscoring the UAE’s success in establishing a competitive and innovative life sciences industry aligned with the nation’s Centennial 2071 vision.
